{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:42:25Z","timestamp":1787499745269,"version":"build-2736575974"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2017,7,6]],"date-time":"2017-07-06T00:00:00Z","timestamp":1499299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1038\/bjc.2017.215","type":"journal-article","created":{"date-parts":[[2017,7,6]],"date-time":"2017-07-06T18:48:06Z","timestamp":1499366886000},"page":"704-709","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["Correlation between circulating mutant DNA and metabolic tumour burden in advanced non-small cell lung cancer patients"],"prefix":"10.1038","volume":"117","author":[{"given":"Anne","family":"Winther-Larsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Demuth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Fledelius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Tranberg","family":"Madsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Hjorthaug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Meldgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boe Sandahl","family":"Sorensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,7,6]]},"reference":[{"key":"BFbjc2017215_CR1","doi-asserted-by":"publisher","first-page":"224ra24","DOI":"10.1126\/scitranslmed.3007094","volume":"6","author":"C Bettegowda","year":"2014","unstructured":"Bettegowda C, Sausen M, Leary RJ, Kinde I, Wang Y, Agrawal N, Bartlett BR, Wang H, Luber B, Alani RM, Antonarakis ES, Azad NS, Bardelli A, Brem H, Cameron JL, Lee CC, Fecher LA, Gallia GL, Gibbs P, Le D, Giuntoli RL, Goggins M, Hogarty MD, Holdhoff M, Hong S-M, Jiao Y, Juhl HH, Kim JJ, Siravegna G, Laheru DA, Lauricella C, Lim M, Lipson EJ, Marie SKN, Netto GJ, Oliner KS, Olivi A, Olsson L, Riggins GJ, Sartore-Bianchi A, Schmidt K, Shih L-M, Oba-Shinjo SM, Siena S, Theodorescu D, Tie J, Harkins TT, Veronese S, Wang T-L, Weingart JD, Wolfgang CL, Wood LD, Xing D, Hruban RH, Wu J, Allen PJ, Schmidt CM, Choti MA, Velculescu VE, Kinzler KW, Vogelstein B, Papadopoulos N, Diaz LA (2014) Detection of circulating tumor DNA in early- and late-stage human malignancies. Sci Transl Med 6: 224ra24.","journal-title":"Sci Transl Med"},{"key":"BFbjc2017215_CR2","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1056\/NEJMoa1213261","volume":"368","author":"S-J Dawson","year":"2013","unstructured":"Dawson S-J, Tsui DWY, Murtaza M, Biggs H, Rueda OM, Chin S-F, Dunning MJ, Gale D, Forshew T, Mahler-Araujo B, Rajan S, Humphray S, Becq J, Halsall D, Wallis M, Bentley D, Caldas C, Rosenfeld N (2013) Analysis of circulating tumor DNA to monitor metastatic breast cancer. N Engl J Med 368: 1199\u20131209.","journal-title":"N Engl J Med"},{"key":"BFbjc2017215_CR3","doi-asserted-by":"publisher","first-page":"16368","DOI":"10.1073\/pnas.0507904102","volume":"102","author":"F Diehl","year":"2005","unstructured":"Diehl F, Li M, Dressman D, He Y, Shen D, Szabo S, Diaz LA, Goodman SN, David KA, Juhl H, Kinzler KW, Vogelstein B (2005) Detection and quantification of mutations in the plasma of patients with colorectal tumors. Proc Natl Acad Sci 102: 16368\u201316373.","journal-title":"Proc Natl Acad Sci"},{"key":"BFbjc2017215_CR4","first-page":"181","volume":"1775","author":"M Fleischhacker","year":"2007","unstructured":"Fleischhacker M, Schmidt B (2007) Circulating nucleic acids (CNAs) and cancer\u2014a survey. Biochim Biophys Acta 1775: 181\u2013232.","journal-title":"Biochim Biophys Acta"},{"key":"BFbjc2017215_CR5","doi-asserted-by":"publisher","first-page":"4586","DOI":"10.1158\/1078-0432.CCR-15-0584","volume":"21","author":"JS Frenel","year":"2015","unstructured":"Frenel JS, Carreira S, Goodall J, Roda D, Perez-Lopez R, Tunariu N, Riisnaes R, Miranda S, Figueiredo I, Nava-Rodrigues D, Smith A, Leux C, Garcia-Murillas I, Ferraldeschi R, Lorente D, Mateo J, Ong M, Yap TA, Banerji U, Gasi Tandefelt D, Turner N, Attard G, de Bono JS (2015) Serial next-generation sequencing of circulating cell-free DNA evaluating tumor clone response to molecularly targeted drug administration. Clin Cancer Res 21: 4586\u20134596.","journal-title":"Clin Cancer Res"},{"key":"BFbjc2017215_CR6","doi-asserted-by":"crossref","first-page":"6330","DOI":"10.18632\/oncotarget.14064","volume":"8","author":"Y Gao","year":"2016","unstructured":"Gao Y, Zhang K, Xi H, Cai A, Wu X, Cui J, Li J, Qiao Z, Wei B, Chen L (2016) Diagnostic and prognostic value of circulating tumor DNA in gastric cancer: a meta-analysis. Oncotarget 8: 6330\u20136340.","journal-title":"Oncotarget"},{"key":"BFbjc2017215_CR7","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/bjc.2016.175","volume":"115","author":"N Hadano","year":"2016","unstructured":"Hadano N, Murakami Y, Uemura K, Hashimoto Y, Kondo N, Nakagawa N, Sueda T, Hiyama E (2016) Prognostic value of circulating tumour DNA in patients undergoing curative resection for pancreatic cancer. Br J Cancer 115: 59\u201365.","journal-title":"Br J Cancer"},{"key":"BFbjc2017215_CR8","first-page":"1659","volume":"61","author":"S Jahr","year":"2001","unstructured":"Jahr S, Hentze H, Englisch S, Hardt D, Fackelmayer FO, Hesch RD, Knippers R (2001) DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells. Cancer Res 61: 1659\u20131665.","journal-title":"Cancer Res"},{"key":"BFbjc2017215_CR9","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1001\/jamaoncol.2014.257","volume":"1","author":"N Karachaliou","year":"2015","unstructured":"Karachaliou N, Mayo-de las Casas C, Queralt C, de Aguirre I, Melloni B, Cardenal F, Garcia-Gomez R, Massuti B, S\u00e1nchez JM, Porta R, Ponce-Aix S, Moran T, Carcereny E, Felip E, Bover I, Insa A, Reguart N, Isla D, Vergnenegre A, de Marinis F, Gervais R, Corre R, Paz-Ares L, Morales-Espinosa D, Viteri S, Drozdowskyj A, Jordana-Ariza N, Ramirez-Serrano JL, Molina-Vila MA, Rosell R Spanish Lung Cancer Group (2015) Association of EGFR L858R mutation in circulating free DNA with survival in the EURTAC trial. JAMA Oncol 1: 149\u2013157.","journal-title":"JAMA Oncol"},{"key":"BFbjc2017215_CR10","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S1095-0397(99)00016-3","volume":"2","author":"SM Larson","year":"1999","unstructured":"Larson SM, Erdi Y, Akhurst T, Mazumdar M, Macapinlac HA, Finn RD, Casilla C, Fazzari M, Srivastava N, Yeung HWD, Humm JL, Guillem J, Downey R, Karpeh M, Cohen AE, Ginsberg R (1999) Tumor treatment response based on visual and quantitative changes in global tumor glycolysis using PET-FDG imaging. The visual response score and the change in total lesion glycolysis. Clin Positron Imaging 2: 159\u2013171.","journal-title":"Clin Positron Imaging"},{"key":"BFbjc2017215_CR11","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1002\/ijc.10526","volume":"100","author":"T Lecomte","year":"2002","unstructured":"Lecomte T, Berger A, Zinzindohou\u00e9 F, Micard S, Landi B, Blons H, Beaune P, Cugnenc P-H, Laurent-Puig P (2002) Detection of free-circulating tumor-associated DNA in plasma of colorectal cancer patients and its association with prognosis. Int J cancer 100: 542\u2013548.","journal-title":"Int J cancer"},{"key":"BFbjc2017215_CR12","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1038\/sj.bjc.6690158","volume":"79","author":"RD Leek","year":"1999","unstructured":"Leek RD, Landers RJ, Harris AL, Lewis CE (1999) Necrosis correlates with high vascular density and focal macrophage infiltration in invasive carcinoma of the breast. Br J Cancer 79: 991\u2013995.","journal-title":"Br J Cancer"},{"key":"BFbjc2017215_CR13","first-page":"646","volume":"37","author":"SA Leon","year":"1977","unstructured":"Leon SA, Shapiro B, Sklaroff DM, Yaros MJ (1977) Free DNA in the serum of cancer patients and the effect of therapy. Cancer Res 37: 646\u2013650.","journal-title":"Cancer Res"},{"issue":"12 Suppl 1","key":"BFbjc2017215_CR14","doi-asserted-by":"publisher","first-page":"S209","DOI":"10.1517\/14712598.2012.688023","volume":"12","author":"F Mouliere","year":"2012","unstructured":"Mouliere F, Thierry AR (2012) The importance of examining the proportion of circulating DNA originating from tumor, microenvironment and normal cells in colorectal cancer patients. Expert Opin Biol Ther 12 (12 Suppl 1): S209\u2013S215.","journal-title":"Expert Opin Biol Ther"},{"key":"BFbjc2017215_CR15","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1038\/nm.3519","volume":"20","author":"AM Newman","year":"2014","unstructured":"Newman AM, Bratman SV, To J, Wynne JF, Eclov NCW, Modlin LA, Liu CL, Neal JW, Wakelee HA, Merritt RE, Shrager JB, Loo BW, Alizadeh AA, Diehn M (2014) An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage. Nat Med 20: 548\u2013554.","journal-title":"Nat Med"},{"key":"BFbjc2017215_CR16","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/bjc.2013.705","volume":"110","author":"AD Nygaard","year":"2014","unstructured":"Nygaard AD, Holdgaard PC, Spindler K-LG, Pallisgaard N, Jakobsen A (2014) The correlation between cell-free DNA and tumour burden was estimated by PET\/CT in patients with advanced NSCLC. Br J Cancer 110: 363\u2013368.","journal-title":"Br J Cancer"},{"key":"BFbjc2017215_CR17","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.cca.2015.04.015","volume":"446","author":"N Pallisgaard","year":"2015","unstructured":"Pallisgaard N, Spindler K-LG, Andersen RF, Brandslund I, Jakobsen A (2015) Controls to validate plasma samples for cell free DNA quantification. Clin Chim Acta 446: 141\u2013146.","journal-title":"Clin Chim Acta"},{"key":"BFbjc2017215_CR18","doi-asserted-by":"publisher","first-page":"e1002199","DOI":"10.1371\/journal.pmed.1002199","volume":"13","author":"N P\u00e9cuchet","year":"2016","unstructured":"P\u00e9cuchet N, Zonta E, Didelot A, Combe P, Thibault C, Gibault L, Lours C, Rozenholc Y, Taly V, Laurent-Puig P, Blons H, Fabre E (2016) Base-Position error rate analysis of next-generation sequencing applied to circulating tumor DNA in non-small cell lung cancer: a prospective study. PLOS Med 13: e1002199.","journal-title":"PLOS Med"},{"key":"BFbjc2017215_CR19","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/nrc3066","volume":"11","author":"H Schwarzenbach","year":"2011","unstructured":"Schwarzenbach H, Hoon DSB, Pantel K (2011) Cell-free nucleic acids as biomarkers in cancer patients. Nat Rev Cancer 11: 426\u2013437.","journal-title":"Nat Rev Cancer"},{"key":"BFbjc2017215_CR20","doi-asserted-by":"publisher","first-page":"3896","DOI":"10.1002\/cncr.28964","volume":"120","author":"BS Sorensen","year":"2014","unstructured":"Sorensen BS, Wu L, Wei W, Tsai J, Weber B, Nexo E, Meldgaard P (2014) Monitoring of epidermal growth factor receptor tyrosine kinase inhibitor-sensitizing and resistance mutations in the plasma DNA of patients with advanced non-small cell lung cancer during treatment with erlotinib. Cancer 120: 3896\u20133901.","journal-title":"Cancer"},{"key":"BFbjc2017215_CR21","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s10555-016-9629-x","volume":"35","author":"AR Thierry","year":"2016","unstructured":"Thierry AR, El Messaoudi S, Gahan PB, Anker P, Stroun M (2016) Origins, structures, and functions of circulating DNA in oncology. Cancer Metastasis Rev 35: 347\u2013376.","journal-title":"Cancer Metastasis Rev"},{"key":"BFbjc2017215_CR22","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1093\/bib\/bbs017","volume":"14","author":"H Thorvaldsd\u00f3ttir","year":"2013","unstructured":"Thorvaldsd\u00f3ttir H, Robinson JT, Mesirov JP (2013) Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration. Brief Bioinform 14: 178\u2013192.","journal-title":"Brief Bioinform"},{"key":"BFbjc2017215_CR23","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1093\/annonc\/mdv177","volume":"26","author":"J Tie","year":"2015","unstructured":"Tie J, Kinde I, Wang Y, Wong HL, Roebert J, Christie M, Tacey M, Wong R, Singh M, Karapetis CS, Desai J, Tran B, Strausberg RL, Diaz LA, Papadopoulos N, Kinzler KW, Vogelstein B, Gibbs P (2015) Circulating tumor DNA as an early marker of therapeutic response in patients with metastatic colorectal cancer. Ann Oncol 26: 1715\u20131722.","journal-title":"Ann Oncol"},{"issue":"Suppl 1","key":"BFbjc2017215_CR24","doi-asserted-by":"publisher","first-page":"122S","DOI":"10.2967\/jnumed.108.057307","volume":"50","author":"RL Wahl","year":"2009","unstructured":"Wahl RL, Jacene H, Kasamon Y, Lodge MA (2009) From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors. J Nucl Med 50 (Suppl 1): 122S\u2013150S.","journal-title":"J Nucl Med"},{"key":"BFbjc2017215_CR25","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/nrc.2017.7","volume":"17","author":"JCM Wan","year":"2017","unstructured":"Wan JCM, Massie C, Garcia-Corbacho J, Mouliere F, Brenton JD, Caldas C, Pacey S, Baird R, Rosenfeld N (2017) Liquid biopsies come of age: towards implementation of circulating tumour DNA. Nat Rev Cancer 17: 223\u2013238.","journal-title":"Nat Rev Cancer"},{"key":"BFbjc2017215_CR26","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.lungcan.2016.01.024","volume":"94","author":"A Winther-Larsen","year":"2016","unstructured":"Winther-Larsen A, Fledelius J, Sorensen BS, Meldgaard P (2016) Metabolic tumor burden as marker of outcome in advanced EGFR wild-type NSCLC patients treated with erlotinib. Lung Cancer 94: 81\u201387.","journal-title":"Lung Cancer"},{"key":"BFbjc2017215_CR27","doi-asserted-by":"publisher","first-page":"e0159094","DOI":"10.1371\/journal.pone.0159094","volume":"11","author":"E Zonta","year":"2016","unstructured":"Zonta E, Garlan F, P\u00e9cuchet N, Perez-Toralla K, Caen O, Milbury C, Didelot A, Fabre E, Blons H, Laurent-Puig P, Taly V (2016) Multiplex detection of rare mutations by picoliter droplet based digital PCR: sensitivity and specificity considerations. PLoS One 11: e0159094.","journal-title":"PLoS One"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/bjc2017215.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/bjc2017215","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/bjc.2017.215","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/bjc2017215.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T09:38:34Z","timestamp":1684402714000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bjc2017215"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,6]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["BFbjc2017215"],"URL":"https:\/\/doi.org\/10.1038\/bjc.2017.215","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,6]]},"assertion":[{"value":"12 May 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}